查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1361737

全球研究抗体和试剂市场报告

Global Research Antibodies & Reagents Market Report
出版日期: | 出版商: Value Market Research | 英文 310 Pages | 商品交期: 最快1-2个工作天内

价格

全球研究抗体和试剂市场的需求预计将从 2022 年的 140.1 亿美元增至 2030 年的近 299.8 亿美元，2023-2030 年研究期间复合年增长率为 8.82%。

研究抗体和试剂通常用于检测未缀合的一抗，一抗进一步用于标靶抗原。研究抗体和试剂产品有助于在流式细胞仪、ELISA、免疫组织化学等不同应用中检测、测量和纯化蛋白质或生物分子。

市场动态：

为了研究再现性而对高品质抗体的需求增加是推动研究抗体和试剂市场成长的主要因素之一。此外，医疗健康研发投资的增加预计将推动研究抗体和试剂市场的成长。生物科学和生物技术在医疗保健和製药领域不断增长的应用正在推动需求。此外，生命科学产业投资的增加正在推动对研究抗体和试剂的需求。此外，产学界合作的增加以及干细胞和神经生物学研究领域的兴起进一步影响了研究抗体和试剂市场。然而，与识别和开发潜在抗体相关的高成本和时间预计将阻碍市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球研究抗体和试剂市场的各个细分市场进行了包容性评估。研究抗体和试剂行业的成长和趋势为这项研究提供了整体方法。

区域分析：

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲研究抗体和试剂市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。研究抗体和试剂市场的主要参与者包括 Thermo Fisher Scientific, Inc.（美国）、Merck KGaA（德国）、Abcam plc（英国）、Becton、Dickinson, and Company（美国）、Bio-Rad Laboratories（美国） 、 Cell Signaling Technology（美国）、F. Hoffmann-La Roche（瑞士）、Danaher Corporation（美国）、Agilent Technologies（美国）、PerkinElmer（美国）、Lonza（瑞士）、GenScript（中国）和BioLegend（美国） 。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：研究抗体和试剂 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按产品分類的市场吸引力分析
    • 按类型分類的市场吸引力分析
    • 按形式分類的市场吸引力分析
    • 按来源分類的市场吸引力分析
    • 按研究领域分類的市场吸引力分析
    • 按技术分類的市场吸引力分析
    • 市场吸引力分析：依应用分类
    • 最终用户的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：COVID-19 爆发的影响分析

第 6 章：全球研究抗体与试剂市场销售：按产品分类

  • 按产品概述
  • 历史和预测销售数据
  • 按产品分析
  • 试剂
  • 媒体与血清
  • 污渍和染料
  • 固定剂
  • 缓衝器
  • 溶剂
  • 酵素
  • 探头
  • 其他试剂
  • 抗体

第 7 章：全球研究抗体与试剂市场分析：按类型

  • 按类型概述
  • 历史和预测销售数据
  • 按类型分析
  • 一抗
  • 二抗

第 8 章：全球研究抗体与试剂市场分析：依形式

  • 表格概述
  • 历史和预测销售数据
  • 形式分析
  • 单复製
  • 多克隆
  • 重组

第 9 章：全球研究抗体与试剂市场分析：依来源分类

  • 按来源概述
  • 历史和预测销售数据
  • 按来源分析
  • 老鼠
  • 兔子
  • 其他来源

第 10 章：全球研究抗体与试剂市场分析：按研究领域

  • 研究领域概述
  • 历史和预测销售数据
  • 按研究领域分析
  • 肿瘤学
  • 传染性疾病
  • 免疫学
  • 神经生物学
  • 干细胞
  • 其他研究领域

第 11 章：全球研究抗体和试剂市场分析：按技术分类

  • 依技术概述
  • 历史和预测销售数据
  • 依技术分析
  • 蛋白质印迹法
  • 流式细胞仪
  • 酵素连结免疫吸附测定法 (ELISA)
  • 免疫组织化学
  • 免疫萤光
  • 免疫沉淀
  • 其他技术

第 12 章：全球研究抗体和试剂市场分析：按应用分类

  • 概述：按应用
  • 历史和预测销售数据
  • 分析：按应用
  • 蛋白质体学
  • 药物开发
  • 基因组学

第 13 章：全球研究抗体和试剂市场分析：按最终用户

  • 最终用户概述
  • 历史和预测销售数据
  • 最终用户分析
  • 製药与生物技术产业
  • 学术研究机构
  • 合约研究组织

第 14 章：全球研究抗体和试剂市场分析：按地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区国家/地区销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 15 章：研究抗体和试剂公司的竞争格局

  • 研究抗体和试剂市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 16 章：公司简介

  • 公司股份分析
  • 市场集中度
  • Thermo Fisher Scientific Inc. (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Merck KGaA (Germany)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Abcam plc (UK)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Becton
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Dickinson and Company (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Bio-Rad Laboratories (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Cell Signaling Technology (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • F. Hoffmann-La Roche (Switzerland)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Danaher Corporation (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Agilent Technologies (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • PerkinElmer (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Lonza (Switzerland)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • GenScript (China)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • BioLegend (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

Product Code: VMR11218746

The global demand for Research Antibodies & Reagents Market is presumed to reach the market size of nearly USD 29.98 BN by 2030 from USD 14.01 BN in 2022 with a CAGR of 8.82% under the study period 2023 - 2030.

Research antibodies & reagents are generally utilized to detect an unconjugated primary antibody which is further used to target antigen. Research antibodies & reagent products assist in detecting, measuring and purifying proteins or biomolecules in different applications such as flow cytometry, ELISA, immunohistochemistry and more.

MARKET DYNAMICS:

The rise in demand for high-quality antibodies for research reproducibility is one of the major factors driving the growth of the research antibodies and reagents market. Moreover, rising investment in medical and health R&D is expected to fuel growth in the research antibodies and reagents market. The growing applications of biosciences and biotechnology in healthcare and pharmaceutical fields are driving demand. Furthermore, increased investment in the life sciences industry is driving up the need for research antibodies and reagents. Additionally, the increase in industry-academia collaboration and rising stem cell and neurobiology research field further influences the research antibodies and reagents market. However, the high cost and time related to identifying and developing potential antibodies are expected to hamper the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of research antibodies & reagents. The growth and trends of research antibodies & reagents industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the research antibodies & reagents market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Reagent
  • Media & Sera
  • Stains & Dyes
  • Fixatives
  • Buffers
  • Solvents
  • Enzymes
  • Probes
  • Other Reagents
  • Antibodies

By Type

  • Primary Antibodies
  • Secondary Antibodies

By Form

  • Monoclonal
  • Polyclonal
  • Recombinant

By Source

  • Mice
  • Rabbits
  • Other Sources

By Research Area

  • Oncology
  • Infectious Diseases
  • Immunology
  • Neurobiology
  • Stem Cells
  • Other Research Areas

By Technology

  • Western Blotting
  • Flow Cytometry
  • Enzyme-Linked Immunosorbent Assay (Elisa)
  • Immunohistochemistry
  • Immunofluorescence
  • Immunoprecipitation
  • Other Technologies

By Application

  • Proteomics
  • Drug Development
  • Genomics

By End User

  • Pharmaceutical & Biotechnologies Industries
  • Academic & Research Institutions
  • Contract Research Organizations

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Research Antibodies & Reagents market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the research antibodies & reagents market include Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Abcam plc (UK), Becton, Dickinson, and Company (US), Bio-Rad Laboratories (US), Cell Signaling Technology (US), F. Hoffmann-La Roche (Switzerland), Danaher Corporation (US), Agilent Technologies (US), PerkinElmer (US), Lonza (Switzerland), GenScript (China), and BioLegend (US). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . RESEARCH ANTIBODIES & REAGENTS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Type
    • 3.7.3 Market Attractiveness Analysis By Form
    • 3.7.4 Market Attractiveness Analysis By Source
    • 3.7.5 Market Attractiveness Analysis By Research Area
    • 3.7.6 Market Attractiveness Analysis By Technology
    • 3.7.7 Market Attractiveness Analysis By Application
    • 3.7.8 Market Attractiveness Analysis By End User
    • 3.7.9 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SALES BY PRODUCT

  • 6.1 Overview by Product
  • 6.2 Historical and Forecast Sales Data
  • 6.3 Analysis by Product
  • 6.4 Reagent Historic and Forecast Sales by Regions
  • 6.5 Media & Sera Historic and Forecast Sales by Regions
  • 6.6 Stains & Dyes Historic and Forecast Sales by Regions
  • 6.7 Fixatives Historic and Forecast Sales by Regions
  • 6.8 Buffers Historic and Forecast Sales by Regions
  • 6.9 Solvents Historic and Forecast Sales by Regions
  • 6.10. Enzymes Historic and Forecast Sales by Regions
  • 6.11 Probes Historic and Forecast Sales by Regions
  • 6.12 Other Reagents Historic and Forecast Sales by Regions
  • 6.13 Antibodies Historic and Forecast Sales by Regions

7 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY TYPE

  • 7.1 Overview by Type
  • 7.2 Historical and Forecast Sales Data
  • 7.3 Analysis by Type
  • 7.4 Primary Antibodies Historic and Forecast Sales by Regions
  • 7.5 Secondary Antibodies Historic and Forecast Sales by Regions

8 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY FORM

  • 8.1 Overview by Form
  • 8.2 Historical and Forecast Sales Data
  • 8.3 Analysis by Form
  • 8.4 Monoclonal Historic and Forecast Sales by Regions
  • 8.5 Polyclonal Historic and Forecast Sales by Regions
  • 8.6 Recombinant Historic and Forecast Sales by Regions

9 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY SOURCE

  • 9.1 Overview by Source
  • 9.2 Historical and Forecast Sales Data
  • 9.3 Analysis by Source
  • 9.4 Mice Historic and Forecast Sales by Regions
  • 9.5 Rabbits Historic and Forecast Sales by Regions
  • 9.6 Other Sources Historic and Forecast Sales by Regions

10 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY RESEARCH AREA

  • 10.1 Overview by Research Area
  • 10.2 Historical and Forecast Sales Data
  • 10.3 Analysis by Research Area
  • 10.4 Oncology Historic and Forecast Sales by Regions
  • 10.5 Infectious Diseases Historic and Forecast Sales by Regions
  • 10.6 Immunology Historic and Forecast Sales by Regions
  • 10.7 Neurobiology Historic and Forecast Sales by Regions
  • 10.8 Stem Cells Historic and Forecast Sales by Regions
  • 10.9 Other Research Areas Historic and Forecast Sales by Regions

11 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY TECHNOLOGY

  • 11.1 Overview by Technology
  • 11.2 Historical and Forecast Sales Data
  • 11.3 Analysis by Technology
  • 11.4 Western Blotting Historic and Forecast Sales by Regions
  • 11.5 Flow Cytometry Historic and Forecast Sales by Regions
  • 11.6 Enzyme-linked Immunosorbent Assay (ELISA) Historic and Forecast Sales by Regions
  • 11.7 Immunohistochemistry Historic and Forecast Sales by Regions
  • 11.8 Immunofluorescence Historic and Forecast Sales by Regions
  • 11.9 Immunoprecipitation Historic and Forecast Sales by Regions
  • 11.1 Other Technologies Historic and Forecast Sales by Regions

12 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY APPLICATION

  • 12.1 Overview by Application
  • 12.2 Historical and Forecast Sales Data
  • 12.3 Analysis by Application
  • 12.4 Proteomics Historic and Forecast Sales by Regions
  • 12.5 Drug Development Historic and Forecast Sales by Regions
  • 12.6 Genomics Historic and Forecast Sales by Regions

13 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY END USER

  • 13.1 Overview by End User
  • 13.2 Historical and Forecast Sales Data
  • 13.3 Analysis by End User
  • 13.4 Pharmaceutical & Biotechnologies Industries Historic and Forecast Sales by Regions
  • 13.5 Academic & Research Institutions Historic and Forecast Sales by Regions
  • 13.6 Contract Research Organizations Historic and Forecast Sales by Regions

14 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY GEOGRAPHY

  • 14.1. Regional Outlook
  • 14.2. Introduction
  • 14.3. North America Sales Analysis
    • 14.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 14.3.2. North America By Segment Sales Analysis
    • 14.3.3. North America By Country Sales Analysis
    • 14.3.4. United State Sales Analysis
    • 14.3.5. Canada Sales Analysis
    • 14.3.6. Mexico Sales Analysis
  • 14.4. Europe Sales Analysis
    • 14.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 14.4.2. Europe by Segment Sales Analysis
    • 14.4.3. Europe by Country Sales Analysis
    • 14.4.4. United Kingdom Sales Analysis
    • 14.4.5. France Sales Analysis
    • 14.4.6. Germany Sales Analysis
    • 14.4.7. Italy Sales Analysis
    • 14.4.8. Russia Sales Analysis
    • 14.4.9. Rest Of Europe Sales Analysis
  • 14.5. Asia Pacific Sales Analysis
    • 14.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 14.5.2. Asia Pacific by Segment Sales Analysis
    • 14.5.3. Asia Pacific by Country Sales Analysis
    • 14.5.4. China Sales Analysis
    • 14.5.5. India Sales Analysis
    • 14.5.6. Japan Sales Analysis
    • 14.5.7. South Korea Sales Analysis
    • 14.5.8. Australia Sales Analysis
    • 14.5.9. Rest Of Asia Pacific Sales Analysis
  • 14.6. Latin America Sales Analysis
    • 14.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 14.6.2. Latin America by Segment Sales Analysis
    • 14.6.3. Latin America by Country Sales Analysis
    • 14.6.4. Brazil Sales Analysis
    • 14.6.5. Argentina Sales Analysis
    • 14.6.6. Peru Sales Analysis
    • 14.6.7. Chile Sales Analysis
    • 14.6.8. Rest of Latin America Sales Analysis
  • 14.7. Middle East & Africa Sales Analysis
    • 14.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 14.7.2. Middle East & Africa by Segment Sales Analysis
    • 14.7.3. Middle East & Africa by Country Sales Analysis
    • 14.7.4. Saudi Arabia Sales Analysis
    • 14.7.5. UAE Sales Analysis
    • 14.7.6. Israel Sales Analysis
    • 14.7.7. South Africa Sales Analysis
    • 14.7.8. Rest Of Middle East And Africa Sales Analysis

15 . COMPETITIVE LANDSCAPE OF THE RESEARCH ANTIBODIES & REAGENTS COMPANIES

  • 15.1. Research Antibodies & Reagents Market Competition
  • 15.2. Partnership/Collaboration/Agreement
  • 15.3. Merger And Acquisitions
  • 15.4. New Product Launch
  • 15.5. Other Developments

16 . COMPANY PROFILES OF RESEARCH ANTIBODIES & REAGENTS INDUSTRY

  • 16.1. Company Share Analysis
  • 16.2. Market Concentration Rate
  • 16.3. Thermo Fisher Scientific Inc. (US)
    • 16.3.1. Company Overview
    • 16.3.2. Company Revenue
    • 16.3.3. Products
    • 16.3.4. Recent Developments
  • 16.4. Merck KGaA (Germany)
    • 16.4.1. Company Overview
    • 16.4.2. Company Revenue
    • 16.4.3. Products
    • 16.4.4. Recent Developments
  • 16.5. Abcam plc (UK)
    • 16.5.1. Company Overview
    • 16.5.2. Company Revenue
    • 16.5.3. Products
    • 16.5.4. Recent Developments
  • 16.6. Becton
    • 16.6.1. Company Overview
    • 16.6.2. Company Revenue
    • 16.6.3. Products
    • 16.6.4. Recent Developments
  • 16.7. Dickinson and Company (US)
    • 16.7.1. Company Overview
    • 16.7.2. Company Revenue
    • 16.7.3. Products
    • 16.7.4. Recent Developments
  • 16.8. Bio-Rad Laboratories (US)
    • 16.8.1. Company Overview
    • 16.8.2. Company Revenue
    • 16.8.3. Products
    • 16.8.4. Recent Developments
  • 16.9. Cell Signaling Technology (US)
    • 16.9.1. Company Overview
    • 16.9.2. Company Revenue
    • 16.9.3. Products
    • 16.9.4. Recent Developments
  • 16.10. F. Hoffmann-La Roche (Switzerland)
    • 16.10.1. Company Overview
    • 16.10.2. Company Revenue
    • 16.10.3. Products
    • 16.10.4. Recent Developments
  • 16.11. Danaher Corporation (US)
    • 16.11.1. Company Overview
    • 16.11.2. Company Revenue
    • 16.11.3. Products
    • 16.11.4. Recent Developments
  • 16.12. Agilent Technologies (US)
    • 16.12.1. Company Overview
    • 16.12.2. Company Revenue
    • 16.12.3. Products
    • 16.12.4. Recent Developments
  • 16.13. PerkinElmer (US)
    • 16.13.1. Company Overview
    • 16.13.2. Company Revenue
    • 16.13.3. Products
    • 16.13.4. Recent Developments
  • 16.14. Lonza (Switzerland)
    • 16.14.1. Company Overview
    • 16.14.2. Company Revenue
    • 16.14.3. Products
    • 16.14.4. Recent Developments
  • 16.15. GenScript (China)
    • 16.15.1. Company Overview
    • 16.15.2. Company Revenue
    • 16.15.3. Products
    • 16.15.4. Recent Developments
  • 16.16. BioLegend (US)
    • 16.16.1. Company Overview
    • 16.16.2. Company Revenue
    • 16.16.3. Products
    • 16.16.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product (USD MN)
  • Reagent Market Sales by Geography (USD MN)
  • Media & Sera Market Sales by Geography (USD MN)
  • Stains & Dyes Market Sales by Geography (USD MN)
  • Fixatives Market Sales by Geography (USD MN)
  • Buffers Market Sales by Geography (USD MN)
  • Solvents Market Sales by Geography (USD MN)
  • Enzymes Market Sales by Geography (USD MN)
  • Probes Market Sales by Geography (USD MN)
  • Other Reagents Market Sales by Geography (USD MN)
  • Antibodies Market Sales by Geography (USD MN)
  • Analysis Market by Type (USD MN)
  • Primary Antibodies Market Sales by Geography (USD MN)
  • Secondary Antibodies Market Sales by Geography (USD MN)
  • Analysis by Form (USD MN)
  • Monoclonal Market Sales by Geography (USD MN)
  • Polyclonal Market Sales by Geography (USD MN)
  • Recombinant Market Sales by Geography (USD MN)
  • Analysis by Source (USD MN)
  • Mice Market Sales by Geography (USD MN)
  • Rabbits Market Sales by Geography (USD MN)
  • Other Sources Market Sales by Geography (USD MN)
  • Analysis by Research Area (USD MN)
  • Oncology Market Sales by Geography (USD MN)
  • Infectious Diseases Market Sales by Geography (USD MN)
  • Immunology Market Sales by Geography (USD MN)
  • Neurobiology Market Sales by Geography (USD MN)
  • Stem Cells Market Sales by Geography (USD MN)
  • Other Research Areas Market Sales by Geography (USD MN)
  • Analysis by Technology (USD MN)
  • Western Blotting Market Sales by Geography (USD MN)
  • Flow Cytometry Market Sales by Geography (USD MN)
  • Enzyme-linked Immunosorbent Assay (ELISA) Market Sales by Geography (USD MN)
  • Immunohistochemistry Market Sales by Geography (USD MN)
  • Immunofluorescence Market Sales by Geography (USD MN)
  • Immunoprecipitation Market Sales by Geography (USD MN)
  • Other Technologies Market Sales by Geography (USD MN)
  • Analysis by Application (USD MN)
  • Proteomics Market Sales by Geography (USD MN)
  • Drug Development Market Sales by Geography (USD MN)
  • Genomics Market Sales by Geography (USD MN)
  • Analysis by End User (USD MN)
  • Pharmaceutical & Biotechnologies Industries Market Sales by Geography (USD MN)
  • Academic & Research Institutions Market Sales by Geography (USD MN)
  • Contract Research Organizations Market Sales by Geography (USD MN)
  • Global Research Antibodies & Reagents Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Research Antibodies & Reagents Report
  • Market Research Process
  • Market Research Methodology
  • Global Research Antibodies & Reagents Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Form
  • Market Attractiveness Analysis by Source
  • Market Attractiveness Analysis by Research Area
  • Market Attractiveness Analysis by Technology
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by End User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product (USD MN)
  • Reagent Market Sales by Geography (USD MN)
  • Media & Sera Market Sales by Geography (USD MN)
  • Stains & Dyes Market Sales by Geography (USD MN)
  • Fixatives Market Sales by Geography (USD MN)
  • Buffers Market Sales by Geography (USD MN)
  • Solvents Market Sales by Geography (USD MN)
  • Enzymes Market Sales by Geography (USD MN)
  • Probes Market Sales by Geography (USD MN)
  • Other Reagents Market Sales by Geography (USD MN)
  • Antibodies Market Sales by Geography (USD MN)
  • Global Market Analysis by Type (USD MN)
  • Primary Antibodies Market Sales by Geography (USD MN)
  • Secondary Antibodies Market Sales by Geography (USD MN)
  • Global Market Analysis by Form (USD MN)
  • Monoclonal Market Sales by Geography (USD MN)
  • Polyclonal Market Sales by Geography (USD MN)
  • Recombinant Market Sales by Geography (USD MN)
  • Global Market Analysis by Source (USD MN)
  • Mice Market Sales by Geography (USD MN)
  • Rabbits Market Sales by Geography (USD MN)
  • Other Sources Market Sales by Geography (USD MN)
  • Global Market Analysis by Research Area (USD MN)
  • Oncology Market Sales by Geography (USD MN)
  • Infectious Diseases Market Sales by Geography (USD MN)
  • Immunology Market Sales by Geography (USD MN)
  • Neurobiology Market Sales by Geography (USD MN)
  • Stem Cells Market Sales by Geography (USD MN)
  • Other Research Areas Market Sales by Geography (USD MN)
  • Global Market Analysis by Technology (USD MN)
  • Western Blotting Market Sales by Geography (USD MN)
  • Flow Cytometry Market Sales by Geography (USD MN)
  • Enzyme-linked Immunosorbent Assay (ELISA) Market Sales by Geography (USD MN)
  • Immunohistochemistry Market Sales by Geography (USD MN)
  • Immunofluorescence Market Sales by Geography (USD MN)
  • Immunoprecipitation Market Sales by Geography (USD MN)
  • Other Technologies Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Proteomics Market Sales by Geography (USD MN)
  • Drug Development Market Sales by Geography (USD MN)
  • Genomics Market Sales by Geography (USD MN)
  • Global Market Analysis by End User (USD MN)
  • Pharmaceutical & Biotechnologies Industries Market Sales by Geography (USD MN)
  • Academic & Research Institutions Market Sales by Geography (USD MN)
  • Contract Research Organizations Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.